Breast Image Platform
for Advanced AI-Based
Breast Cancer Screening

Learn more

Uniting 20 partners across Europe to build a dataset of over 1 million cancer images

Supporting the European Cancer Imaging Initiative and advancing AI innovations to improve screening

BreastSCan creates one of Europe’s largest and most diverse breast cancer imaging datasets, with over one million images from nine countries. The project directly contributes to the Cancer Image Europe initiative. 

Learn more

Work plan

Learn how we contribute to earlier detection, better care, and fewer lives lost to breast cancer
Read more

Our Partners

BreastSCan consortium gathers a multidisciplinary group of leading academic institutions, research organisations, and industry partners
Click Here

Research output

Dive into the world of breast screening data and browse the newest research output of the BreastSCan project
Click Here

Expected outcomes

Better quality data

Introduction of common European standards for breast cancer imaging, ensuring scans are more consistent and comparable across countries

Shared platform

Integration of existing and new imaging data into the Cancer Image Europe platform, creating a powerful resource for researchers and doctors from day one

Training healthcare teams

Development of training programs to equip doctors and radiologists with the skills to effectively use new digital tools and AI in clinical practice

Solid infrastructure

Creation of a common, standardised technical backbone to facilitate easy, safe, and secure data sharing across participating hospitals

Smarter diagnostic

Increased adoption of AI tools in hospitals to support faster, more accurate, and more personalised detection of breast cancer

Pan-European reach

Expansion of the dataset to include images from more countries, reflecting Europe’s population diversity and enhancing the applicability of research results

Clear rules and trust

Implementation of standardised processes and strong legal safeguards to ensure that patient health data is used securely and ethically

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Find out more

Open Call Webinar

We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.

WATCH THE RECORDING

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

Sign up for more information

SAVE THE DATE
March 14, 10:00-11:30 aM CET

DISCOVER THE CANCER IMAGE EUROPE PLATFORM

TECHNICAL DEMONSTRATION WEBINAR

Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.

Participate